Team:UT Dallas/Project

From 2011.igem.org

(Difference between revisions)
 
(15 intermediate revisions not shown)
Line 397: Line 397:
<div class="main">
<div class="main">
   <div class="header">
   <div class="header">
-
  <div class = "logo">
+
    <div class = "logo">
 +
   
       <h1><span>UTDallas</span> iGem<small></small></h1>
       <h1><span>UTDallas</span> iGem<small></small></h1>
     </div>
     </div>
-
+
 
     <div class="menu_nav">
     <div class="menu_nav">
Line 406: Line 407:
         <li><a href="https://2011.igem.org/Team:UT_Dallas"><font size="3" face="verdana">Home</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas"><font size="3" face="verdana">Home</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Team"><font size="3" face="verdana">Team</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Team"><font size="3" face="verdana">Team</a></font></li>
-
         <li class = "active"><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="3" face="verdana">Project</a></font></li>
+
         <li class = "active"><a href="#"><font size="3" face="verdana">Project</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Protocols"><font size="3" face="verdana">Protocols</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Protocols"><font size="3" face="verdana">Protocols</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Parts"><font size="3" face="verdana">Parts</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Parts"><font size="3" face="verdana">Parts</a></font></li>
Line 412: Line 413:
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Notebook"><font size="3" face="verdana">Notebook</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Notebook"><font size="3" face="verdana">Notebook</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/HumanPractices"><font size="3" face="verdana">Human Practices</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/HumanPractices"><font size="3" face="verdana">Human Practices</a></font></li>
-
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Gallery"><font size="3" face="verdana">Gallery</a></font></li>
+
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Safety"><font size="3" face="verdana">Safety</a></font></li>
          
          
       </ul>
       </ul>
Line 429: Line 430:
       <div class="mainbar">
       <div class="mainbar">
         <div class="article">
         <div class="article">
-
           <h2><span> UT Dallas iGem Project</span></h2>
+
           <h2><span>Overview</span></h2>
-
           <p> <font size="3" face="verdana">Tissue damage characterizes a range of medical conditions that can be particularly difficult to manage without restrictively risky or expensive intervention. The human body hosts a rich diversity of symbiotic microflora that provides a powerful engineering platform for synthetic bacterial systems. We aim to construct a probiotic solution that successfully interfaces with the immune system to facilitate localized tissue repair. </font></p>
+
           <p> <font size="3" face="verdana">The human bowel hosts a rich diversity of symbiotic microflora that provides a powerful engineering platform for intelligent probiotics. These “immunobots” will ideally work in-sync and enhance natural self-repair mechanisms for a range of intestinal diseases associated with tissue damage. Towards this end, we engineered a bacterial chemotaxis pathway that utilizes a chimeric receptor to successfully interface with the immune system. In addition, we introduced an inducible secondary bacterial population that can trigger system-wide self-destruction, conferring an additional level of user control. Each module of our system was characterized using fluorescent reporters and the integrated parts were evaluated by controlled experiments involving wound signal gradients. We envision a probiotic solution that can facilitate localized tissue repair for damage resulting from inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease.
 +
 
 +
</font></p><br></br>
 +
 
 +
 
 +
<br></br><br></br><br></br><br></br><br></br>
           <div class="clr"></div>
           <div class="clr"></div>
Line 443: Line 449:
               </div>
               </div>
-
          
+
         <!--<div class="pagenavi"><span class="pages">Page 1 of 2</span><span class="current">1</span><a href="#">2</a><a href="#" >&raquo;</a></div>-->
       </div>
       </div>
       <div class="sidebar">
       <div class="sidebar">
Line 459: Line 465:
         <div class="gadget">
         <div class="gadget">
-
           <h2><span></span><font size="5" face="Arial">Explore Our Wiki!</font></h2>
+
           <h2><span></span><font size="5" face="Arial">Subprojects</font></h2>
-
          <div class="clr"></div>
+
-
          <ul class="sb_menu">
+
-
            <li><a href="https://2011.igem.org/Team:UT_Dallas"><font size="3" face="verdana">Home</a></font></li>
+
-
            <li><a href="https://2011.igem.org/Team:UT_Dallas/Team"><font size="3" face="verdana">Team</a></font></li>
+
-
            <li class = "active"><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="4" face="verdana">Project</a></font></li>
+
-
            <li><a href="https://2011.igem.org/Team:UT_Dallas/Protocols"><font size="3" face="verdana">Protocols</a></font></li>
+
            <a href="https://2011.igem.org/wiki/index.php?title=Team:UT_Dallas/ProjectReceptor"><img src="
-
            <li><a href="https://2011.igem.org/Team:UT_Dallas/Parts"><font size="3" face="verdana">Parts</a></font></li>
+
https://static.igem.org/mediawiki/2011/8/86/Receptor.png" width="210" height="43"><br></br>
-
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Modeling"><font size="3" face="verdana">Modeling</a></font></li>
+
             <a href="https://2011.igem.org/Team:UT_Dallas/ProjectPhototaxis"><img        src="https://static.igem.org/mediawiki/2011/d/d6/Phototaxis.png" width="210" height="43"><br></br>
-
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Notebook"><font size="3" face="verdana">Notebook</a></font></li>
+
             <a href="https://2011.igem.org/Team:UT_Dallas/ProjectSuicideMechanism"><img src="
 +
https://static.igem.org/mediawiki/2011/1/16/Suicide_Mechanism.png
-
            <li><a href="https://2011.igem.org/Team:UT_Dallas/HumanPractices"><font size="3" face="verdana">Human Practices</a></font></li>
+
 
-
            <li><a href="https://2011.igem.org/Team:UT_Dallas/Gallery"><font size="3" face="verdana">Gallery</a></font></li>
+
" width="210" height="43"><br></br>
 +
          <div class="clr"></div>
 +
          <ul class="sb_menu">
 +
           
           </ul>
           </ul>
         </div>
         </div>
                       <div class="gadget">
                       <div class="gadget">
-
          <h2 class="grey"><span>Follow us on Twitter!</span></h2>
+
       
           <div class="clr"></div>
           <div class="clr"></div>
           <div class="testi">
           <div class="testi">
-
             <p><span class="q"><img src="https://static.igem.org/mediawiki/2011/8/85/Quote_1.gif" width="16" height="14" alt="" /></span><script src="http://widgets.twimg.com/j/2/widget.js"></script>
+
              
-
<script>
+
-
new TWTR.Widget({
+
-
  version: 2,
+
-
  type: 'faves',
+
-
  rpp: 5,
+
-
  interval: 4000,
+
-
  title: 'Follow us!',
+
-
  subject: 'UTDallas iGem',
+
-
  width: 250,
+
-
  height: 250,
+
-
  theme: {
+
-
    shell: {
+
-
      background: '#298899',
+
-
      color: '#efedf5'
+
-
    },
+
-
    tweets: {
+
-
      background: '#f4f2f7',
+
-
      color: '#1f1d1f',
+
-
      links: '#268f22'
+
-
    }
+
-
  },
+
-
  features: {
+
-
    scrollbar: true,
+
-
    loop: true,
+
-
    live: false,
+
-
    hashtags: true,
+
-
    timestamp: true,
+
-
    avatars: false,
+
-
    behavior: 'default'
+
-
  }
+
-
}).render().setUser('UTDallas_iGem').start();
+
-
</script><span class="q"><img src="https://static.igem.org/mediawiki/2011/a/a1/Quote_2.gif" width="16" height="14" alt="" /></span></p>
+
                 </div>
                 </div>
Line 526: Line 499:
" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/e/e8/Pic_3.jpg" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/2/2a/Pic_4.jpg" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/1/17/Pic_5.jpg" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/7/76/Pic_6.jpg" width="58" height="58" alt="" /></a> </div>
" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/e/e8/Pic_3.jpg" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/2/2a/Pic_4.jpg" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/1/17/Pic_5.jpg" width="58" height="58" alt="" /></a> <a href="#"><img src="https://static.igem.org/mediawiki/2011/7/76/Pic_6.jpg" width="58" height="58" alt="" /></a> </div>
     <div class="col c2">
     <div class="col c2">
-
       <h2><span><font size="5" face="verdana">UT Dallas</span></font></h2>
+
       <h2><span><font size="5" face="arial">UT Dallas</span></font></h2>
-
<img src="https://static.igem.org/mediawiki/2011/a/ad/Nserl_Pic.png" width="112" height="138" alt="" ALIGN = RIGHT />     
+
    <img src="https://static.igem.org/mediawiki/2011/a/ad/Nserl_Pic.png" width="112" height="138" alt="" ALIGN = RIGHT />     
  <p>
  <p>
       </font></p><p><a href="https://2011.igem.org/Team:UT_Dallas/UTDallas"><font size="3" face="verdana">Click here to learn more&nbsp; about UTD</a></font></p>
       </font></p><p><a href="https://2011.igem.org/Team:UT_Dallas/UTDallas"><font size="3" face="verdana">Click here to learn more&nbsp; about UTD</a></font></p>
-
 
-
      <p><br />
 
-
      </a></font></p>
 
     </div>
     </div>
     <div class="col c3">
     <div class="col c3">
-
       <h2><span><font size="5" face="verdana">Notebook</span></font></h2>
+
       <h2><span><font size="5" face="arial">Notebook</span></font></h2>
       <p>
       <p>
</p><p> <a href="https://2011.igem.org/Team:UT_Dallas/Notebook"><font size="3" face="verdana">Learn more...</a></font></p>
</p><p> <a href="https://2011.igem.org/Team:UT_Dallas/Notebook"><font size="3" face="verdana">Learn more...</a></font></p>
Line 542: Line 512:
     <div class="clr"></div>
     <div class="clr"></div>
   </div>
   </div>
-
<div class="footer">
+
  <div class="footer">
     <div class="footer_resize">
     <div class="footer_resize">
-
      <!--<p class="lf">&copy; Copyright <a href="#">MyWebSite</a>.</p>
+
    <!-- <p class="lf">&copy; Copyright <a href="#">MyWebSite</a>.</p>
       <p class="rf">Layout by Cool <a href="http://www.coolwebtemplates.net/">Website Templates</a></p>-->
       <p class="rf">Layout by Cool <a href="http://www.coolwebtemplates.net/">Website Templates</a></p>-->

Latest revision as of 23:59, 5 September 2011

biz solution

Overview

The human bowel hosts a rich diversity of symbiotic microflora that provides a powerful engineering platform for intelligent probiotics. These “immunobots” will ideally work in-sync and enhance natural self-repair mechanisms for a range of intestinal diseases associated with tissue damage. Towards this end, we engineered a bacterial chemotaxis pathway that utilizes a chimeric receptor to successfully interface with the immune system. In addition, we introduced an inducible secondary bacterial population that can trigger system-wide self-destruction, conferring an additional level of user control. Each module of our system was characterized using fluorescent reporters and the integrated parts were evaluated by controlled experiments involving wound signal gradients. We envision a probiotic solution that can facilitate localized tissue repair for damage resulting from inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease.